Cervical cancer rates are on the rise among younger women, owing in part to a lack of screening and prevention.

Palliative chemotherapy is administered to patients with metastatic or recurrent cervical cancer after salvage radiation or surgical therapy; however, an estimated 4,070 patients die from the disease.

Two studies have examined whether additional testing and screening techniques will be valuable for stratifying patients at greater risk of developing life-threatening prostate cancer or cervical ...